Google
HQL 株価分析 — Tekla Life Sciences Investors (Financial Services >> Asset Management)
HQL に関するよくある質問
HQLのPER（株価収益率）は？
Tekla Life Sciences Investors（HQL）は現在PER 2.49倍で取引されています。
HQLのROE（自己資本利益率）は？
Tekla Life Sciences InvestorsのROEは33.16%です。
HQLの配当利回りは？
Tekla Life Sciences Investorsの配当利回りは10.00%です。
HQLの品質スコア（Quality Score）は？
当社のAIはHQLの総合財務品質を100点中92点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
HQLは今が買い時ですか？
当社AIのタイミングスコアは100点中67点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
HQLはどのセクターに属しますか？
Tekla Life Sciences InvestorsはFinancial Services >> Asset Managementセクターに分類されます（NYSE市場）
HQL AI Analysis Summary
Our AI summary for HQL: Tekla Life Sciences Investors (NYSE), Financial Services >> Asset Management sector. The stock currently trades at a P/E of 2.49, ROE of 33.16%, a dividend yield of 10.00%. Its financial Quality Score stands at 92/100 — fundamentals stronger than most of the market. The AI Timing Score is 67/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
この銘柄は高配当リストに掲載 — 配当利回り 10.00%、3年連続支払い
リスト全体を見る ›
|
USD 19.70
Price
0.43
(2.23%)
Day Change
|
|
|---|
HQL, ファンダメンタルスコアはexcellent ( ファンダメンタル = 92) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are ok , financial health is not good , and ability to make profit is good , ...
| Deepscope 分析 |
|
66% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
73
GOOD
|
| Magic Formula Rank by ROE |
73
GOOD
|
| Magic Formula Rank by ROIC |
270
|
| Price | 19.70 |
| PBV / Sector |
1.04 / 1.86
GREAT
|
| Earning Per Share | 6.31 |
| PE / Sector |
2.49 / 13.56
GREAT
|
| PEG or PE/Growth / Sector |
N/A / 0.05
|
| Average 1M Daily Value |
3.07 M
GREAT
|
| Average 1W Daily Value |
2.92 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
77% |
| 配当 |
|
70% |
| 登録情報 |
| Analyze Date | 2026-08-05 08:00:20 |
| Symbol | HQL |
| Name | TEKLA LIFE SCIENCES INVESTORS |
| Sector | Financial Services >> Asset Management |
| Market | NYSE |
| Listed Shares | 30.41 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 580.79 / 7,364.64 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1900 Market Street, Philadelphia, PA, United States, 19103
Phone: 215 405 5700
Website: https://www.teklacap.com/hql.html
Description: Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
ME vs SECTOR Financial Services >> Asset Management
Click a bubble to view stock details · Bubble size represents market capitalization share
